Holen Sie sich die Stockscreener-App
44.06
1.78%
0.77
Handel nachbörslich:
43.80
-0.26
-0.59%
Finanzdaten der Revolution Medicines Inc-Aktie (RVMD)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
100.00%
-
|
0.742 | - | 3.824 | 7.014 |
Operating Expenses
|
22.06%
140.86
|
180.72 | 123.25 | 112.62 | 82.17 |
| Operating Income/Loss |
21.74%
-140.86
|
-179.98 | -123.25 | -108.80 | -75.16 |
| Nonoperating Income/Loss |
32.29%
24.86
|
18.79 | 10.95 | 10.50 | 7.059 |
| Income/Loss From Continuing Operations Before Tax |
28.04%
-116.00
|
-161.19 | -112.30 | -98.30 | -68.10 |
| Income Tax Expense/Benefit |
100.00%
-
|
0.343 | -3.867 | - | - |
| Income/Loss From Continuing Operations After Tax |
28.19%
-116.00
|
-161.54 | -108.43 | -98.30 | -68.10 |
|
Net Income/Loss
|
28.19%
-116.00
|
-161.54 | -108.43 | -98.30 | -68.10 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
1,644%
164.73
|
9.4474 | 109.23 | 106.88 | 94.83 |
| Diluted Average Shares |
1,644%
164.73
|
9.4474 | 109.23 | 106.88 | 94.83 |
| Basic Earnings Per Share |
42.15%
-0.70
|
-1.21 | -0.99 | -0.92 | -0.72 |
| Diluted Earnings Per Share |
42.15%
-0.70
|
-1.21 | -0.99 | -0.92 | -0.72 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):